Foundation Notes
A considered account of how Brastel was built — the decisions made at founding, the standards adopted for sourcing, and the reasoning behind a formulation practice that does not change with season.
Brastel was established in 2021 from a position of deliberate restraint. The Indonesian supplement market at that point was characterised by products making claims that outpaced their published evidence by a considerable margin. The founding position of Brastel was the inverse: begin with what the published nutritional literature actually recommends for men, then assemble a composition that matches that recommendation — nothing more, nothing less.
The first composition was a mineral foundation: zinc and magnesium at concentrations supported by the nutritional reference values published by the applicable food authority. A qualified nutrition professional reviewed the ingredient ratios against the evidence base. The review notes are retained in the founding archive.
What followed was a slow expansion of the range — not driven by market demand, but by the emergence of sufficient published research to justify adding each new ingredient. Vitamin D3 was added in the second year, after a review of the published literature on immune function and the documented prevalence of inadequate intake across working-age men in equatorial climates. CoQ10 followed in 2023, after three independent review papers on cellular energy production were assessed against the projected daily dose.
The Glodok facility was selected for its proximity to a network of independent laboratories that could perform regular batch verification without the extended transit times that would compromise cold-chain compliance records. The facility operates under a documented quality protocol that has been revised four times since founding — each revision is archived with a date and a brief notation of what changed and why.
"There is a considered logic to how a body uses micronutrients across a day — a logic that resists the language of performance marketing."
A dated account of the studio's development
Mineral Foundation Complex — First Production Run
The first batch of Mineral Foundation Complex was produced at the Glodok facility. Lot code GL-2021-001. Zinc and magnesium at concentrations aligned with nutritional reference values. Independent laboratory analysis performed before release. Documentation: revision 01-A, archived September.
Vitamin D3 Added. Six-Supplier Network Established.
Following a review of the published literature on immune function and documented intake levels in equatorial climates, Vitamin D3 was incorporated into the daily composition. A network of six documented suppliers was formalised, each with a signed chain-of-custody agreement. Cold-chain compliance records initiated. Documentation: revision 02-B, archived April.
Energy & Stamina Complex Released. CoQ10 Added.
The Energy and Stamina Complex was released as the second composition in the Brastel range, incorporating Vitamin B12 and CoQ10. Three independent review papers on cellular energy production were assessed prior to final formulation. Documentation: revision 03-A, archived February. Batch archive reaches 20 complete lot records.
Immune & Resilience Daily Completed. Archive Reaches 38 Records.
The third composition — Immune and Resilience Daily — was completed and released, incorporating Vitamin C, Selenium, and an updated Vitamin D3 concentration following a review of the 2024 nutritional literature. The lot record archive reached 38 complete entries. A second production line was added to the Glodok facility. Documentation: revision 04-B, archived March.
A small team with a large archival habit
Brastel operates with a team of six full-time staff and a rotating panel of two independent nutritional consultants who review the research basis for any proposed changes to existing compositions. No reformulation happens without a signed review note from the consultants.
The archival practice at Brastel is deliberate. Every decision — from a supplier change to a serving-size adjustment — is dated, noted, and filed in the lot record archive. This creates a navigable history of the product that any member can request to review. The archive is not a marketing document; it is an operational record.
We recommend speaking with a qualified wellness or nutrition professional before introducing any supplement to your daily routine, particularly if you have specific dietary requirements.
What guides every Brastel decision
Evidence First
Every ingredient requires a published-research basis before it enters the formulation brief. The standard is consistency with the existing nutritional literature, not anecdotal use or historical tradition alone.
Transparency of Record
Every formulation change, every supplier transition, every batch release — recorded, dated, and archived. Members who request a lot record receive the full document, not a summary.
Stable Compositions
No seasonal reformulation. No ingredient swaps driven by supply cost. If a composition changes, the change is documented, the archive entry is revised, and members are informed in writing.
Independent Verification
Third-party laboratory analysis on every batch, without exception. No batch leaves the Glodok facility before a passing verification record is filed. The certificate is retained for audit access.
Documented Sourcing
Named-region materials carry an origin map entry. Cold-chain records accompany every delivery. Supplier agreements are signed and held on file. Traceability is the baseline, not the exception.
Quiet Claims
Brastel products are nutritional food-supplements. They are not positioned as solutions to conditions. The role descriptions used in all communications match the evidence base and the applicable regulatory framework.